These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1101843)

  • 41. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 42. Is amitriptyline + perphenazine superior to doxepin?
    Dilsaver SC; Domino L
    J Clin Psychiatry; 1983 May; 44(5):195. PubMed ID: 6853455
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline)].
    Invernizzi G; Sostero M; Vitali A; Campanella F
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1143-81. PubMed ID: 5143725
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacotherapy of mental disorders with a combination of amitriptyline and perphenazine].
    Molcan J; Belanská M; Motýlová A; Wolf M; Polák L
    Act Nerv Super (Praha); 1968 Oct; 10(3):318. PubMed ID: 5702544
    [No Abstract]   [Full Text] [Related]  

  • 45. [Multicenter study with a combination preparation of amitriptyline and perphenazine. Study of 48 established practicing neurologists].
    Berzewski H; Volsan O; Balss G
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):745-8. PubMed ID: 6415424
    [No Abstract]   [Full Text] [Related]  

  • 46. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination medications in psychiatric treatment: patterns in a group of elderly hospital patients.
    Fracchia J; Sheppard C; Merlis S
    J Am Geriatr Soc; 1971 Apr; 19(4):301-7. PubMed ID: 4936281
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of two drug treatments in depressive illness.
    Browne MW
    Br J Psychiatry; 1969 Jun; 115(523):693-6. PubMed ID: 4896804
    [No Abstract]   [Full Text] [Related]  

  • 49. A controlled trial of combined medications on behavioral and extrapyramidal effects.
    Simpson GM; Krakov L; Kunz-Bartholini E
    Acta Psychiatr Scand Suppl; 1970; 212():20-7. PubMed ID: 4917968
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
    Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
    J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.
    Razani J; White KL; White J; Simpson G; Sloane RB; Rebal R; Palmer R
    Arch Gen Psychiatry; 1983 Jun; 40(6):657-61. PubMed ID: 6342565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data.
    Takeuchi H; Fervaha G; Uchida H; Suzuki T; Bies RR; Grönte D; Remington G
    J Clin Psychiatry; 2014 May; 75(5):506-11. PubMed ID: 24569099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
    Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
    J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacological treatment of delusional depression: Part II.
    Spiker DG; Perel JM; Hanin I; Dealy RS; Griffin SJ; Soloff PH; Weiss JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):339-42. PubMed ID: 3805326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amitriptyline + perphenazine, an effective tranquilizer-antidepressant combination.
    Shubin H; Mandel S
    Psychosomatics; 1967; 8(2):79-81. PubMed ID: 4860194
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic trial of reactive and neurotic depressions with an amitriptyline-perphenazine combination (long term results in 100 cases)].
    Chateau R
    Therapeutique; 1973; 49(5):393-5. PubMed ID: 4592773
    [No Abstract]   [Full Text] [Related]  

  • 59. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
    Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
    Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients.
    Levine J; Caspi N; Laufer N
    Schizophr Res; 1997 Jul; 26(1):55-63. PubMed ID: 9376337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.